They hypothesized that certain levels of SESN2 expression during the early steps of carcinogenesis might be required to support the activity of AKT kinase, the critical positive regulator of glucose transport, anabolism and cell viability that contribute to growth and proliferation of tumour cells. This evidence concerns the gene SESN2 and neoplasm.